Literature DB >> 21477442

Long-term clinical outcome following lower limb arterial angioplasty.

G Morris-Stiff1, M Moawad, N Appleton, G Davies, E Hicks, C Davies, M H Lewis.   

Abstract

INTRODUCTION: The aim of this study was to determine the clinical outcome of lower limb arterial angioplasty in a busy district general hospital practice. PATIENTS AND METHODS: All angioplasties performed from January 1999 to December 2004 were identified and data collected included cardiovascular risk factors, indications for and complications of angioplasty, limb salvage and patient survival rates, and clinically significant re-stenoses.
RESULTS: 471 interventions were performed in 385 patients (231 men, 154 women). The median age was 67.9 years (range: 39-93 years). Indications for angioplasty were critical ischaemia (n=247, 52%) and lifestyle-limiting intermittent claudication (n=224, 48%). Stenotic lesions accounted for 378 (80%) cases and occlusion for 93 (20%). Radiological success was obtained in 417 (88.5%), improving to 93.6% if only those in whom access was achieved were included. Post-angioplasty complications were observed in 42/471 (9.1%) of interventions. The actual patient survival at 1, 2, and 3 years was 87.4%, 85.1% and 83.2% respectively. Indication for angioplasty and the number of lesions present were identified as risk factors for outcome on multivariate analysis. The cumulative post-angioplasty patency rates at 1, 2 and 3 years were 86.0%, 83.1% and 81.6% respectively. The only factor associated with patency was the mode of presentation.
CONCLUSIONS: Angioplasty for lower limb peripheral vascular disease can be performed safely and efficaciously with a high technical success rate and a low complication rate. The patient survival and post-angioplasty patency data reflect the progressive and multi-site nature of the underlying disease process.

Entities:  

Mesh:

Year:  2011        PMID: 21477442      PMCID: PMC3291146          DOI: 10.1308/147870811X566394

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  22 in total

1.  Intermittent claudication: its natural course.

Authors:  A M Imparato; G E Kim; T Davidson; J G Crowley
Journal:  Surgery       Date:  1975-12       Impact factor: 3.982

2.  Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study.

Authors:  G D Smith; M J Shipley; G Rose
Journal:  Circulation       Date:  1990-12       Impact factor: 29.690

3.  Femoropopliteal angioplasty. Factors influencing long-term success.

Authors:  P Capek; G K McLean; H D Berkowitz
Journal:  Circulation       Date:  1991-02       Impact factor: 29.690

4.  The natural history of superficial femoral artery stenoses.

Authors:  D B Walsh; J J Gilbertson; R M Zwolak; S Besso; G C Edelman; J R Schneider; J L Cronenwett
Journal:  J Vasc Surg       Date:  1991-09       Impact factor: 4.268

5.  Femoral and popliteal arteries: reanalysis of results of balloon angioplasty.

Authors:  K W Johnston
Journal:  Radiology       Date:  1992-06       Impact factor: 11.105

6.  The effects of successful intervention on quality of life in patients with varying degrees of lower-limb ischaemia.

Authors:  R Klevsgård; I R Hallberg; B Risberg; M B Thomsen
Journal:  Eur J Vasc Endovasc Surg       Date:  2000-03       Impact factor: 7.069

7.  Intermittent claudication. Current results of nonoperative management.

Authors:  J L Cronenwett; K G Warner; G B Zelenock; W M Whitehouse; L M Graham; M Lindenauer; J C Stanley
Journal:  Arch Surg       Date:  1984-04

8.  Management of cardiovascular risk factors by primary care physicians in patients with peripheral arterial disease.

Authors:  J D'Souza; N N B Patel; M Rocker; E Townsend; G Morris-Stiff; T R Magee; R B Galland; M H Lewis
Journal:  Surgeon       Date:  2008-06       Impact factor: 2.392

9.  The fate of patients with intermittent claudication managed nonoperatively.

Authors:  F F McAllister
Journal:  Am J Surg       Date:  1976-11       Impact factor: 2.565

10.  Risks and benefits of femoropopliteal percutaneous balloon angioplasty.

Authors:  M G Hunink; M C Donaldson; M F Meyerovitz; J F Polak; A D Whittemore; K Kandarpa; C J Grassi; J Aruny; D P Harrington; J A Mannick
Journal:  J Vasc Surg       Date:  1993-01       Impact factor: 4.268

View more
  3 in total

Review 1.  Comparative Analysis of Endovascular Intervention and Endarterectomy in Patients with Femoral Artery Disease: A Systematic Review and Meta-Analysis.

Authors:  Nidhruv Ravikumar; Gopika Sreejith; Sharon Hiu Ching Law; Prakhar Anand; Noah Varghese; Samrin Kagdi; Navneet Kang; Mohamed Nashnoush; Sihat Salam; Ibsen Ongidi
Journal:  Hematol Rep       Date:  2022-06-01

2.  The Role of Complex Treatment in Mixed Leg Ulcers - A Case Report of Vascular, Surgical and Physical Therapy.

Authors:  Uwe Wollina; Birgit Heinig; Christian Stelzner; Gesina Hansel; Jacqueline Schönlebe; Georgi Tchernev; Torello Lotti
Journal:  Open Access Maced J Med Sci       Date:  2018-01-01

3.  Endovascular Treatment for Critical Limb Ischemia in Type II Diabetes Mellitus Involving Femoropopliteal and Infrapopliteal Segments: Revascularization Strategy.

Authors:  Nabil A Al-Zoubi; Nawaf J Shatnawi; Lujain Bakkar; Mohammad Al-Sabah
Journal:  Vasc Health Risk Manag       Date:  2021-03-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.